Reply to the letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial'

被引：0
|
作者：
Branch, Kelley R. H. [1 ]
Gerstein, Hertzel C. [2 ,3 ]
Probstfield, Jeffrey L. [1 ]
机构：
[1] Univ Washington, Inst Heart, Seattle, WA 98195 USA
[2] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada
[3] McMaster Univ, Hamilton, ON, Canada
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2022年 / 24卷 / 11期
关键词：
LIRAGLUTIDE;
D O I：
10.1002/ejhf.2719
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2207 / 2208
页数：2
相关论文
共 50 条
  • [1] Letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial
    Ferreira, Joao Pedro
    Neves, Joao Sergio
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (11)
  • [2] Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: A post-hoc analysis from the REWIND randomized trial
    Branch, Kelley
    Dagenais, G.
    Avezum, A.
    Basile, J.
    Conget, I.
    Cushman, W. C.
    Jansky, P.
    Lakshmanan, M.
    Lanas, F.
    Leitner, L. A.
    Pais, P.
    Pogosova, N.
    Raubenheimer, P. J.
    Gerstein, H.
    Probstfield, J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 158 - 159
  • [3] Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial
    Branch, Kelley R. H.
    Dagenais, Gilles R.
    Avezum, Alvaro
    Basile, Jan
    Conget, Ignacio
    Cushman, William C.
    Jansky, Petr
    Lakshmanan, Mark
    Lanas, Fernando
    Leiter, Lawrence A.
    Pais, Prem
    Pogosova, Nana
    Raubenheimer, Peter J.
    Ryden, Lars
    Shaw, Jonathan E.
    Sheu, Wayne H-H
    Temelkova-Kurktschiev, Theodora
    Bethel, M. Angelyn
    Gerstein, Hertzel C.
    Chinthanie, Ramasundarahettige
    Probstfield, Jeffrey L.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1805 - 1812
  • [4] Gender differences in cardiovascular risk, treatment, and outcomes: a post-hoc analysis from the REWIND trial
    Ferrannini, G.
    Maldonado, J. M.
    Raha, S.
    Rao-Melacini, P.
    Khatun, R.
    Atisso, C.
    Shurzinske, L.
    Gerstein, H.
    Ryden, L.
    Bethel, M. A.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 4 - 5
  • [5] Albiglutide in patients with type 2 diabetes and heart failure: a post-hoc analysis from Harmony Outcomes
    Ferreira, Joao Pedro
    Sharma, Abhinav
    Vasques-Novoa, Francisco
    Angelico-Goncalves, Antonio
    Leite, Ana Rita
    Borges-Canha, Marta
    Carvalho, Davide
    Packer, Milton
    Zannad, Faiez
    Leite-Moreira, Adelino
    Neves, Joao Sergio
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1792 - 1801
  • [6] Response to Letter Regarding Article, "BNP Levels Predict Outcome in Pediatric Heart Failure Patients: Post Hoc Analysis of the Pediatric Carvedilol Trial"
    Auerbach, Scott R.
    Richmond, Marc E.
    Addonizio, Linda J.
    Lamour, Jacqueline M.
    Hsu, Daphne T.
    Blume, Elizabeth D.
    Shaddy, Robert E.
    Mahony, Lynn
    Pahl, Elfriede
    [J]. CIRCULATION-HEART FAILURE, 2010, 3 (06) : E33 - E33
  • [7] Letter by Dietrich et al Regarding Article, "Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes"
    Dietrich, Johannes W.
    Makimoto, Hisaki
    Mueller, Patrick
    [J]. CIRCULATION-HEART FAILURE, 2019, 12 (04)
  • [8] Response by Cappola and Cappola to Letter Regarding Article, "Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes"
    Cappola, Anne R.
    Cappola, Thomas P.
    [J]. CIRCULATION-HEART FAILURE, 2019, 12 (04)
  • [9] Reduction in heart failure hospitalizations by sacubitril/valsartan; a post-hoc analysis of the PARALLAX trial
    Wachter, R.
    Pieske, B.
    Baldridge, A.
    Ibram, G.
    Zhao, Z.
    Shah, S. J.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 791 - 791
  • [10] Response to Letter Regarding Article, "Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial"
    Massie, Barry M.
    Ammon, Susan E.
    Collins, Joseph F.
    Krol, William F.
    Armstrong, Paul W.
    Cleland, John G. F.
    Ezekowitz, Michael
    Jafri, Syed M.
    O'Connor, Christopher M.
    Schulman, Kevin A.
    Teo, Koon
    Warren, Stuart
    [J]. CIRCULATION, 2009, 120 (20) : E165 - E165
12345